Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Claire Jenkinson(University of Liverpool), Eithne Costello(University of Liverpool), John F. Timms(Ludwig Cancer Research), B. Kevin Park(University of Liverpool), William Greenhalf(University of Liverpool), Rosalind E. Jenkins(University of Liverpool), Lucy Oldfield(University of Liverpool), Aleksandra Gentry‐Maharaj(UCL Australia), John P. Neoptolemos(University of Liverpool), Ian Jacobs(Children's Hospital of Philadelphia), Stephen P. Pereira(The Royal Free Hospital), David A. Tuveson(Cold Spring Harbor Laboratory), Evangelia-O Fourkala(Institute for Women's Policy Research), Usha Menon(University of South Florida), Trevor F. Cox(University of Liverpool), Sophia Apostolidou(Institute for Women's Policy Research), Robert Sutton(University of Liverpool), Fiona Campbell(University of Birmingham), Victoria L. Elliott(University of Liverpool), A.G. Evans(Princeton University), Darragh P. O’Brien(Age UK)
Cited by 86
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k
Spontaneous formation of ordered structures in thin films of metals supported on an elastomeric polymer
|Nature|1998|2.3k
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k